Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Eurofins Scientific SE Announces Acquisition Of AROS Applied Biotechnology A/S
Eurofins Scientific SE announced the acquisition of AROS Applied Biotechnology A/S (AROS), provider of genomic solutions in Europe, serving the pharmaceutical industry, as well as academic and public research institutes. Terms of the transaction were not disclosed.
Latest Developments for Eurofins Scientific SE
- Eurofins Scientific SE Announces Acquisition of Majority Stake in GCL Chile
- Eurofins Scientific SE Raises FY 2012 Dividend; Issues FY 2013 EBITDA and Revenue Guidance
- Eurofins Scientific SE Announces Aquisition Of LZV
- Eurofins Scientific SE Continues Asia Pacific Expansion with Acquisition Of mgt-LabMark in Australia and ELS in New Zealand
Latest Key Developments in Biotechnology
- Share this
- Link this
- Digg this


Follow Reuters